Psykey, Inc. (CEOS)
USD 0.02
(72.22%)
USD 0.02
(72.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.72 Million USD | 200.43% |
| 2022 | 574.96 Thousand USD | -8.26% |
| 2021 | 626.7 Thousand USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 209.33 Thousand USD | 0.0% |
| 2018 | 209.33 Thousand USD | 0.0% |
| 2016 | 995 Thousand USD | -15.32% |
| 2015 | 1.17 Million USD | -13.17% |
| 2014 | 1.35 Million USD | 0.0% |
| 2007 | 2.25 Million USD | -71.26% |
| 2006 | 7.85 Million USD | 180818.35% |
| 2005 | 4344.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 1.72 Million USD | 200.43% |
| 2023 Q3 | 1.95 Million USD | 1.05% |
| 2023 Q4 | 1.72 Million USD | -11.85% |
| 2023 Q1 | 569.79 Thousand USD | -0.9% |
| 2023 Q2 | 1.93 Million USD | 240.36% |
| 2022 Q2 | 615.61 Thousand USD | 3.85% |
| 2022 Q4 | 574.96 Thousand USD | -3.42% |
| 2022 FY | 574.96 Thousand USD | -8.26% |
| 2022 Q1 | 592.77 Thousand USD | -5.41% |
| 2022 Q3 | 595.33 Thousand USD | -3.29% |
| 2021 Q1 | 35.09 Thousand USD | 0.0% |
| 2021 FY | 626.7 Thousand USD | 0.0% |
| 2021 Q4 | 626.7 Thousand USD | 9.14% |
| 2021 Q3 | 574.23 Thousand USD | 2610.06% |
| 2021 Q2 | 21.18 Thousand USD | -39.63% |
| 2020 FY | - USD | -100.0% |
| 2019 FY | 209.33 Thousand USD | 0.0% |
| 2018 FY | 209.33 Thousand USD | 0.0% |
| 2016 FY | 995 Thousand USD | -15.32% |
| 2015 FY | 1.17 Million USD | -13.17% |
| 2014 FY | 1.35 Million USD | 0.0% |
| 2008 Q2 | 938.3 Thousand USD | -38.22% |
| 2008 Q3 | 197.18 Thousand USD | -78.99% |
| 2008 Q1 | 1.51 Million USD | -32.75% |
| 2007 FY | 2.25 Million USD | -71.26% |
| 2007 Q4 | 2.25 Million USD | -15.55% |
| 2007 Q1 | 5.78 Million USD | -26.36% |
| 2007 Q3 | 2.67 Million USD | -38.75% |
| 2007 Q2 | 4.36 Million USD | -24.56% |
| 2006 Q4 | 7.85 Million USD | 39.35% |
| 2006 Q2 | 4.21 Million USD | -33.46% |
| 2006 FY | 7.85 Million USD | 180818.35% |
| 2006 Q1 | 6.33 Million USD | 0.0% |
| 2006 Q3 | 5.63 Million USD | 33.83% |
| 2005 FY | 4344.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 6.023% |
| Ansell Limited | 3.23 Billion USD | 99.947% |
| Ansell Limited | 3.24 Billion USD | 99.947% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.647% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -475.093% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.953% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.953% |
| Encision Inc. | 3.81 Million USD | 54.671% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -164.981% |
| LifePoint, Inc. | 8.8 Million USD | 80.391% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 89.174% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -93.001% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 68.531% |
| Reflect Scientific, Inc. | 2.66 Million USD | 35.278% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.711% |
| Sector 10, Inc. | 1000.00 USD | -172636.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.964% |
| SheerVision, Inc. | 837.56 Thousand USD | -106.236% |
| United Health Products, Inc. | 284.64 Thousand USD | -506.851% |
| Vasamed, Inc. | 1.6 Million USD | -7.944% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -674.0% |
| Yubo International Biotech Limited | 2.34 Million USD | 26.45% |